language_icon
EN
HI

Global Health Share price

MEDANTA

1242.5

30.60 (2.52%)
NSE
BSE
Last updated on 15 May, 2026 | 15:56 IST
Today's High

1278.00

Today's Low

1220.90

52 Week Low

956.00

52 Week High

1456.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Global Health Chart

Global Health Share Key Metrics

Volume
7.81 L
Market Cap
33397.20 CR
LTQ@LTP
100@1242.50
ATP
1254.33
Var Margin
16.25 %
Circuit Range
969.6-1454.2
Delivery %
63.15 %
Value
97.91 CR
ASM/GSM
No
Market Lot
1

Summary

15 May, 2026 | 15:56 को, Global Health का शेयर प्राइस आज ₹1242.5 पर है, जो दिन के लिए 30.60% की 2.52 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1220.90 और ₹1278.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹956.00 से ₹1456.50 तक रही है। ट्रेडिंग गतिविधि के मामले में, Global Health ने 780605 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹268790382 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹125433 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 100,124250 रही। यह स्टॉक ₹969.6-1454.2 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹97.91 CR है। दिन के लिए डिलीवरी परसेंटेज 63.15% रही। इसके अतिरिक्त, Global Health वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Global Health Fundamentals

View More
P/E Ratio

60.02

P/B Ratio

8.42

Div. Yield

0.04

Sector P/E

56.28

Sector P/B

-15.69

Sec. Div. Yield

1.98

Global Health Resistance and Support

Pivot 1216.03

Resistance

First Resistance

1237.66

Second Resistance

1263.43

Third Resistance

1285.06

Support

First Support

1190.26

Second Support

1168.63

Third Support

1142.86

Global Health Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

33.01%

Mutual Fund

13.91%

Insurance

0.62%

Foreign Institutional Investors

10.15%

Domestic Institutional Investors

0.23%

Retail

42.08%

Others

0%

Total Promoters
MAR '26
33.01%

Global Health Corporate Actions

DateAgenda
2026-05-14Audited Results & Final Dividend
2026-02-04Quarterly Results

Global Health News

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Global Health has provided a link to the audio recording of its earnings conference call held on May 15, 2026. The call, hosted by ICICI Securities, discussed the company's financial results for Q4 FY26 and the full financial year.
May 15 2026 16:05:00

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Global Health announced strong Q4 FY26 results with total income increasing 25.3% YoY to Rs.11,958 million. Net profit for the quarter grew 39.7% YoY to Rs.1,417 million, driven by robust operational performance and patient volume growth.
May 14 2026 18:05:00

Global Health Limited

Global Health's board has declared a final dividend of Rs.0.50 per equity share for the financial year 2025-26. This dividend is equivalent to 25% of the face value. The record date will be announced closer to the Annual General Meeting date.
May 14 2026 17:05:00

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Change in Management

Global Health announced key leadership changes. Kedar Ashok Apte has been appointed as Chief Marketing & Growth Officer, and Jagdeep Singh as General Counsel and Senior Management Personnel, both effective May 14, 2026. This strengthens the company's strategic leadership.
May 14 2026 17:05:00

Global Health Ltd - 543654 - Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.

Global Health Limited reported Q4 FY26 consolidated revenue of ₹11,590.47 mn and net profit of ₹1,416.53 mn, up 45% and 40% YoY respectively. The company also recommended a final dividend of ₹0.50 per equity share and appointed two Senior Management Personnel (SMPs).
May 14 2026 16:05:00

Global Health Ltd - 543654 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend.

Global Health's Board of Directors is scheduled to meet on May 14, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026, and recommending a final dividend.
May 06 2026 15:05:00

Global Health Limited

Medanta will acquire an 80-bed Cancer Hospital in Indore from Asian Institute of Oncology for ₹30 crores, expanding its oncology program. This acquisition strengthens its presence in Central India and is expected to drive operational synergies.
Apr 27 2026 15:04:00

Global Health Limited

Global Health acquired a 79-bedded cancer care hospital business in Indore from Asian Institute of Oncology Private Limited for a cash consideration of ₹30 crores. This acquisition will expand the Medanta network and is expected to complete by September 30, 2026, subject to regulatory approvals.
Apr 27 2026 14:04:00

Global Health Limited

Global Health (Medanta) board approved the acquisition of a 79-bedded cancer care hospital in Indore for ₹30 crores cash. This strategic move strengthens the company's oncology services and regional presence.
Apr 27 2026 14:04:00

Global Health Limited

Global Health (Medanta) board approved the acquisition of a 79-bedded cancer care hospital in Indore for ₹30 crores cash. This strategic move strengthens the company's oncology services and regional presence.
Apr 27 2026 14:04:00
Read More

About Global Health AboutThe

NSE : 11956  
BSE : 543654  
ISIN : INE474Q01031  

Our Company was incorporated as ‘Global Health Private Limited’ on August 13 2004 at New Delhi India as a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act 2013 pursuant to a special resolution passed by our Shareholders in the EGM held on July 31 2021 and consequently the name of our Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e. Investor Selling Shareholder) invested in our Company-1st Joint Commission International (“JCI”) accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary GHPPL entered into a 33-year concession agreement with Governor of Bihar for the development operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital’s outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital’s inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy

Read More

Global Health Management

NamePosition
Rahul RanjanCompany Secretary & Compliance Officer
Naresh TrehanChairman & Managing Director
View More

Global Health FAQs

Global Health शेयर का खरीद मूल्य 1242.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Global Health शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Global Health शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 60.02 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Global Health शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 8.42 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Global Health शेयर का प्राइस-टू-बुक (पी/बी) रेशियो -15.69 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Global Health का मार्केट कैप 33397.20 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Global Health शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1456.50 और 956.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost